Mologic and University College London Hospitals collaborating in major clinical trial for early detection of sepsis
Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis
Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis
This launch represents an important step in Roche’s personalized healthcare strategy to fit treatments to patients who can benefit most from a specific medicine
The new 3D MRI computing technique calculates strain in heart muscles showing which muscles are not functioning enough without damaging other organs
Movement bans are often used to control outbreaks of infectious diseases such as bovine tuberculosis (bTB) in livestock
The Barostim Neo System was given a Breakthrough Device designation by the FDA
The U.S. Food and Drug Administration has approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis
The cobas TV/MG test promises to provide the flexibility to process up to four sexually transmitted infections from one patient sample
Abbott's AlinIQ Integrated Platform analyzes currently siloed datasets to help hospitals make more informed decisions based on their unique needs
Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests
We celebrate the clinical laboratory products that have made the most difference to your lab work or point-of-care testing and reveal our most popular clinical content of the year
Company will showcase its new and next-generation products, including Ortho’s VITROS® XT 7600 Integrated System
AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro
Combination of Tecentriq and chemotherapy has demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit
Landmark 15-year study funded by the MS Society has potential to predict the progression of the condition
RSV test represents expansion of FDA-cleared, CLIA-waived and CE-marked PCR point-of-care testing portfolio
Established through a $1,000,000 gift from Fujifilm to Harvard Medical School, the program will advance education and research in the field of translational medicine.
Side effects are similar to injectable glucagon, with the addition of nasal and eye-related symptoms